Vascular Solutions says a federal judge granted a preliminary injunction against sales of Boston Scientific's Guidezilla catheter.
Vascular Solutions (NSDQ:VASC) claimed a win in its patent infringement lawsuit against Boston Scientific (NYSE:BSX) over the Guidezilla catheter, saying a federal judge granted a preliminary injunction against U.S. sales of the BSX device.
Vascular Solutions sued the Natick, Mass.-based medical device company in May, alleging infringement of guided catheter patents in what Vascular Solutions CEO Howard Root at the time called "1 of the most blatant plagiarisms of a patented medical device that I have ever encountered."
The lawsuit, filed in the U.S. District Court for Minnesota, alleges that Boston Scientific's Guidezilla catheter "is a copy of VSI’s GuideLiner catheter. Guidezilla’s design, materials, and dimensions are materially the same as those of GuideLiner and those described and claimed in the patents-in-suit," according to court documents.